Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03299853

Ligand	Ligand name	Chain	PDB	Tanimoto
G27	(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL	A	2G9R	0.8
G27	(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL	A	2G9U	0.8
1PC	1-(PHENYL-1-CYCLOHEXYL)PIPERIDINE	B,C	2PCP	0.73
PIR	2-(4-AMINO-PHENYL)-5-HYDROXYMETHYL-PYRROLIDINE-3,4-DIOL	A,B,C,D	2MAS	0.72
2SK	(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL	A	2F7P	0.73
K7I	L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide	A,B	2QXG	0.72
HC6	(2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium)	A,B	3F2R	0.72
HC6	(2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium)	A,B	3G15	0.72
GB3	(2R,3R,4S,5R)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)-5-METHYLPYRROLIDINE-3,4-DIOL	A	2F1B	0.8
K30	(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide	A,B	3CJO	0.77
S13	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	A	2QRQ	0.71
216	[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE	B	1HWR	0.82
SK3	(1R,2R,3S,4S,5R)-5-(BENZYLAMINO)CYCLOPENTANE-1,2,3,4-TETROL	A	2F7R	0.76
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	A,B,I	1ZSR	0.73
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1ZJ7	0.73
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1ZLF	0.73
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1HEG	0.73
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1FQX	0.73
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	A,B,I	1IIQ	0.73
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1HEF	0.73
BS1	(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE	A,F	2W8F	0.71
XK2	[4R-(4ALPHA,5ALPHA,6BETA,7BETA)]-HEXAHYDRO-5,6-DIHYDROXY-1,3-BIS[2-NAPHTHYL-METHYL]-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPIN-2-ONE	A,B	1HVR	0.75
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1ZSF	0.73
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A	1JLD	0.73
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B	1IDA	0.73
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B	1IDB	0.73
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1Z8C	0.73
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1ZBG	0.73
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1ZPK	0.73
BAV	(3S,14R,16S)-16-[(1R)-1-hydroxy-2-{[3-(1-methylethyl)benzyl]amino}ethyl]-3,4,14-trimethyl-1,4-diazacyclohexadecane-2,5-dione	A,B,C	3DV5	0.71
PHL	L-PHENYLALANINOL	A,B	1JOH	0.7
PHL	L-PHENYLALANINOL	I	3APR	0.7
PHL	L-PHENYLALANINOL	A	1DLZ	0.7
PHL	L-PHENYLALANINOL	A	1IH9	0.7
PHL	L-PHENYLALANINOL	A	1OB4	0.7
PHL	L-PHENYLALANINOL	I	2ER6	0.7
PHL	L-PHENYLALANINOL	A	1R9U	0.7
PHL	L-PHENYLALANINOL	A	1OB7	0.7
PHL	L-PHENYLALANINOL	A,B	1OB6	0.7
PHL	L-PHENYLALANINOL	A,B,C	1AMT	0.7
PDH	(2S)-2-AMINO-3-PHENYL-1-PROPANOL	A	1GQ0	0.7
LOB	LOBELINE	A,B,C,D,E,F,G,H,I,J	2BYS	0.73
DMQ	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-1,3-BIS([(3-AMINO)PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPINONE	B	1RQ9	0.73
DMQ	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-1,3-BIS([(3-AMINO)PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPINONE	A,B	1DMP	0.73
DMQ	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-1,3-BIS([(3-AMINO)PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPINONE	A	1MER	0.73
Q82	{[4-R(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-1,3-BIS(4-HYDROXYMETHYL)METHYL]-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPIN-2-YLIDENE]CYANAMIDE}	B	1HVH	0.73
COR	2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE	A	9HVP	0.76
GB7	(3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)-1-methylpyrrolidin-2-one	A	3DDG	0.71
GB1	(2R,3R,4S)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	A	2F18	0.79
TA2	(2R,3S)-3-AMINO-3-PHENYLPROPANE-1,2-DIOL	A,B	2IFR	0.77
VBZ	(1R,4R,5R,7R,8R)-2-Benzyl-5-hydroxymethyl-2-aza-bicyclo[2.2.2]octane-4,7,8-triol	A,B	2VO5	0.86
DMP	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)]-2H-1,3-DIAZEPINONE	B	1BVG	0.75
DMP	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)]-2H-1,3-DIAZEPINONE	B	1MES	0.75
DMP	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)]-2H-1,3-DIAZEPINONE	A	1MET	0.75
DMP	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)]-2H-1,3-DIAZEPINONE	A,B	1QBS	0.75
DMP	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)]-2H-1,3-DIAZEPINONE	B	1BVE	0.75
DMP	[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)]-2H-1,3-DIAZEPINONE	A	1MEU	0.75
GB2	(2R,3R,4S)-2-({[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	A	2F1A	0.79